Toxoplasmosis.
Montoya JG, Liesenfeld O.
Lancet. 2004 Jun 12;363(9425):1965-76. doi: 10.1016/S0140-6736(04)16412-X.
Toxoplasmosis in pregnancy: prevention, screening, and treatment.
Paquet C, Yudin MH; Society of Obstetricians and Gynaecologists of Canada.
J Obstet Gynaecol Can. 2013 Jan;35(1):78-81. doi: 10.1016/s1701-2163(15)31053-7.
Congenital Toxoplasmosis: The State of the Art.
Bollani L, Auriti C, Achille C, Garofoli F, De Rose DU, Meroni V, Salvatori G, Tzialla C.
Front Pediatr. 2022 Jul 6;10:894573. doi: 10.3389/fped.2022.894573. eCollection 2022.
Congenital toxoplasmosis.
Kieffer F, Wallon M.
Handb Clin Neurol. 2013;112:1099-101. doi: 10.1016/B978-0-444-52910-7.00028-3.
Ocular Findings in Infants with Congenital Toxoplasmosis after a Toxoplasmosis Outbreak.
Conceição AR, Belucik DN, Missio L, Gustavo Brenner L, Henrique Monteiro M, Ribeiro KS, Costa DF, Valadão MCDS, Commodaro AG, de Oliveira Dias JR, Belfort R Jr.
Ophthalmology. 2021 Sep;128(9):1346-1355. doi: 10.1016/j.ophtha.2021.03.009. Epub 2021 Mar 10.
Antiparasitic agents.
Rosenblatt JE.
Mayo Clin Proc. 1999 Nov;74(11):1161-75. doi: 10.4065/74.11.1161.
Cerebral Toxoplasmosis.
Nath A, Sinai AP.
Curr Treat Options Neurol. 2003 Jan;5(1):3-12. doi: 10.1007/s11940-003-0018-8.
Sulfadiazine plasma concentrations in women with pregnancy-acquired compared to ocular toxoplasmosis under pyrimethamine and sulfadiazine therapy: a case-control study.
Reiter-Owona I, Hlobil H, Enders M, Klarmann-Schulz U, Gruetzmacher B, Rilling V, Hoerauf A, Garweg JG.
Eur J Med Res. 2020 Nov 23;25(1):59. doi: 10.1186/s40001-020-00458-7.
[Ocular toxoplasmosis].
Pleyer U, Torun N, Liesenfeld O.
Ophthalmologe. 2007 Jul;104(7):603-15, quiz 616. doi: 10.1007/s00347-007-1535-8.
Ocular toxoplasmosis in pregnancy.
Kump LI, Androudi SN, Foster CS.
Clin Exp Ophthalmol. 2005 Oct;33(5):455-60. doi: 10.1111/j.1442-9071.2005.01061.x.
